Skip to content
NewsBlazeAU – Lifestyle
Author:
Arexera Therapeutics
Arexera Therapeutics Highlights Potentially Best-in-Class Preclinical Profile and Initiates Clinical Development for ATL-101 in Huntington’s Disease
November 16, 2026
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington’s Disease Franchise
October 14, 2026